Growing community of inventors

Lansdale, PA, United States of America

David E McClure

Average Co-Inventor Count = 2.14

ph-index = 7

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 128

David E McClureJohn J Baldwin (17 patents)David E McClureJoseph G Atkinson (7 patents)David E McClureDavid A Claremon (3 patents)David E McClureSteven M Pitzenberger (1 patent)David E McClureDavid E McClure (20 patents)John J BaldwinJohn J Baldwin (229 patents)Joseph G AtkinsonJoseph G Atkinson (30 patents)David A ClaremonDavid A Claremon (147 patents)Steven M PitzenbergerSteven M Pitzenberger (12 patents)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Merck + Co., Inc. (19 from 4,770 patents)

2. Merck Sharp + Dohme Corp. (2 from 2,405 patents)

3. Other (1 from 832,680 patents)


20 patents:

1. 4816457 - Aralkylaminoethanol heterocyclic compounds

2. 4686222 - Aralkylaminoethanol heterocyclic compounds

3. 4677102 - Substituted diazapines and derivatives thereof useful in the treatment

4. 4677101 - Substituted dihydroazepines useful as calcium channel blockers

5. 4675321 - Substituted pyrimidines useful as calcium channel blockers

6. 4656168 - (3-aralkylamino-2-or-propoxy)heterocyclic compounds in method of

7. 4609494 - 5-acetyl-3,4,5,6-tetrahydro-4-oxo-2,6-methano-2H-1,3,5-benzothiazoci

8. 4588824 - Preparation of epihalohydrin enantiomers

9. 4568679 - Aralkylaminoethanol heterocyclic compounds

10. 4533745 - Amino ketones and their preparation

11. 4486446 - Aralkylaminoethanol heterocyclic compounds

12. 4472427 - (Aralkylamino-2-OR-propoxy)heterocyclic compounds

13. 4442094 - (3-Aralkylamino-2-or-propoxy)heterocyclic compounds

14. 4431647 - Method of use of enantiomers of trans-indeno[1,2-b]-1,4-oxazines

15. 4408063 - Preparation of epihalohydrin enantiomers

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/8/2025
Loading…